Nox 1 and 4 inhibition in type 1 diabetic kidney disease
This study is looking for:
People aged 18 to 70 years and old who have T1D and a;
HbA1C less than 10% and;
Albumin (protein) in the urine
About this study
This study will test whether a new tablet can help to treat diabetic kidney disease. The study will last for 56 weeks, and participants will be allocated to receive either the new tablet or placebo. There will be 10 study visits.